Compare Stocks → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:FONASDAQ:PHARCVE:RTNTSE:SRX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFOFalcon Oil & GasC$0.12C$0.15C$0.07▼C$0.22C$124.80M0.64200,674 shs773,218 shsPHARPharming Group$9.61-8.0%$10.86$9.27▼$16.71$644.93M0.162,610 shs1,703 shsRTNReturn EnergyC$0.04+40.0%C$0.03C$0.02▼C$0.04C$914KN/A11.77 million shs13.47 million shsSRXStorm ResourcesC$6.27C$1.98▼C$6.52C$767.72MN/A354,569 shs89,715 shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFOFalcon Oil & Gas0.00%-7.69%-11.11%-27.27%-27.27%PHARPharming Group-2.93%-0.16%-11.36%-22.01%-11.81%RTNReturn Energy0.00%0.00%0.00%0.00%0.00%SRXStorm Resources0.00%0.00%0.00%0.00%0.00%The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFOFalcon Oil & GasN/AN/AN/AN/AN/AN/AN/AN/APHARPharming Group2.5834 of 5 stars3.55.00.00.02.60.00.6RTNReturn EnergyN/AN/AN/AN/AN/AN/AN/AN/ASRXStorm ResourcesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFOFalcon Oil & GasN/AN/AN/AN/APHARPharming Group3.00Buy$37.00285.02% UpsideRTNReturn EnergyN/AN/AN/AN/ASRXStorm ResourcesN/AN/AN/AN/ACurrent Analyst RatingsLatest SRX, PHAR, RTN, FO, and SAVP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/14/2024PHARPharming GroupHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$37.00(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFOFalcon Oil & GasN/AN/AC$0.02 per share6.25C$0.04 per shareN/APHARPharming Group$245.32M2.63$0.10 per share100.85$3.26 per share2.95RTNReturn EnergyC$1.54M0.59C$0.01 per share3.33C$0.01 per share4.38SRXStorm ResourcesC$257.21M0.00N/AN/AC$3.41 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFOFalcon Oil & Gas-C$3.54MN/AN/A∞N/AN/A-7.81%-4.12%5/28/2024 (Estimated)PHARPharming Group-$10.55M-$0.14N/AN/AN/A-4.13%-4.53%-2.14%5/8/2024 (Confirmed)RTNReturn EnergyN/A-C$0.01N/A∞N/AN/AN/AN/AN/ASRXStorm ResourcesN/AC$0.0792.21N/AN/AN/AN/AN/AN/ALatest SRX, PHAR, RTN, FO, and SAVP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2024N/APHARPharming Group$0.0050N/A-$0.0050N/AN/AN/A3/14/2024Q4 2023PHARPharming Group$0.05-$0.03-$0.08-$0.02$71.83 million$81.20 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFOFalcon Oil & GasN/AN/AN/AN/AN/APHARPharming GroupN/AN/AN/AN/AN/ARTNReturn EnergyC$3.479,914.29%N/AN/A N/ASRXStorm ResourcesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFOFalcon Oil & GasN/A4.6851.52PHARPharming Group0.624.063.33RTNReturn Energy168.129.439.36SRXStorm Resources21.170.310.31OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFOFalcon Oil & Gas5.45%PHARPharming Group0.03%RTNReturn EnergyN/ASRXStorm ResourcesN/AInsider OwnershipCompanyInsider OwnershipFOFalcon Oil & Gas28.74%PHARPharming Group2.07%RTNReturn EnergyN/ASRXStorm ResourcesN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableFOFalcon Oil & Gas51.04 billionN/ANot OptionablePHARPharming Group33267.11 million65.72 millionNot OptionableRTNReturn EnergyN/A26.11 millionN/ANot OptionableSRXStorm Resources27122.44 millionN/ANot OptionableSRX, PHAR, RTN, FO, and SAVP HeadlinesSourceHeadlineLIST: Resources available for those impacted by Rock Hill stormmsn.com - April 26 at 4:26 PMAgainst The Storm's 1.3 update is out now and it's one for the zoomersrockpapershotgun.com - April 23 at 8:11 PMStorm Resiliency and Response Checklist for Energy Utilitiescsrwire.com - April 18 at 2:18 AMCrews rescue man stuck overnight in a storm drainky3.com - April 17 at 9:06 PMHouston flood protection: How it works, and why it sometimes doesn’thoustonchronicle.com - April 17 at 4:06 PMBBB issues warning over ‘storm chasers’ who prey on victims of natural disasterswlox.com - April 17 at 4:06 PMRed Cross opens Resource Center for Mississippi storm victimsmsn.com - April 17 at 10:32 AMPart of our region under a rare level 3 severe storm threat for tonightwtkr.com - April 15 at 3:38 PMLocal artists turn Norman's storm drains into works of artnormantranscript.com - April 14 at 1:39 PM‘How to Listen When Markets Speak’ Review: The Gathering Stormmsn.com - April 12 at 3:06 PMSevere weather brings storm damage to the ArkLaMissmsn.com - April 10 at 4:04 PMTexas power outage map: Powerful storm leaves over 100,000 homes, businesses without powermsn.com - April 10 at 9:55 AM'Storm ready': LU becomes Virginia's Region 3 Coordination Center and 'storm certified'msn.com - April 8 at 10:53 PMRoswell locals can get free storm-spotter trainingkrqe.com - April 3 at 3:58 PM'Against The Storm' Sells Over 1 Million Copiesworthplaying.com - March 27 at 9:04 PMNetwork Infrastructure: A rising cyber battlegroundscmagazine.com - February 28 at 12:43 PMWith AI exploding data centre power use, software that hunts for clean energy globally gains currencystraitstimes.com - February 26 at 1:17 AMSan Diego storm resource guide: Small business grants, help centers and morenbcsandiego.com - February 25 at 8:28 AMTIMELINE: Monday storm upgraded to Level 3 with chance of severe thunderstormsmsn.com - February 19 at 11:13 AMThe hidden costs of a hidden stormitemlive.com - February 18 at 10:13 PMStrong Winter Storm Soaks San Diego Area Againmsn.com - February 8 at 11:15 AMHere's Where to Turn for Resources as Residents Brace for Another Powerful Stormmsn.com - February 5 at 11:56 AMScientists debunk California biblical-storm hysteria swirling on internetsfgate.com - January 29 at 5:42 PMShayne Looper: A biblical model for handling church conflictsnews.yahoo.com - January 12 at 3:37 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioCaterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesApril 25, 2024 10:36 AMView Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeCharles Schwab Fortifies its Uptrend on EPS Beat April 23, 2024 10:15 AMView Charles Schwab Fortifies its Uptrend on EPS Beat All Headlines Company DescriptionsFalcon Oil & GasCVE:FOFalcon Oil & Gas Ltd., an oil and gas company, engages in the exploration, and development of unconventional oil and gas assets in Australia, South Africa, and Hungary. The company holds 22.5% interests in three exploration permits covering an area of approximately 1 million net acres in the Beetaloo Sub-basin, Northern Territory, Australia. It also holds a 100% interest in the technical cooperation permit covering an area of approximately 30,327.9 square kilometers in the southwest Karoo Basin, South Africa; and a 100% interest in the Makó production license covering an area of approximately 994.6 square kilometers in the Makó Trough located in south-eastern Hungary. The company was incorporated in 1980 and is headquartered in Dublin, Ireland.Pharming GroupNASDAQ:PHARPharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.Return EnergyCVE:RTNReturn Energy Inc. engages in the exploration for, development, and production of petroleum and natural gas properties in the Western Canadian Sedimentary Basin. The company holds interests in the producing oil and gas assets in the Peace River Arch Area of Northwest Alberta. It primarily owns and operates a 100% interest in the Rycroft gas plant and associated gathering system. The company was formerly known as DualEx Energy International Inc. and changed its name to Return Energy Inc. in December 2016. Return Energy Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.Storm ResourcesTSE:SRXStorm Resources Ltd. operates as a crude oil and natural gas exploration and development company in Canada. The company primarily owns interests in lands covering an area of 120,000 net acres located in Umbach, Nig Creek, and Fireweed areas of Northeast British Columbia. As of December 31, 2020, it had 49,134 thousand barrels of oil equivalent of total proved plus probable reserves. Storm Resources Ltd. was incorporated in 2010 and is headquartered in Calgary, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.